SAN DIEGO, Sept. 26, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® will be exhibiting its line of cannabidiol (CBD) hemp oil products at the Cannabis World Congress and Business Expo, taking place in Los Angeles from September 27-29.
"As CBD continues to gain significant attention in the health and wellness community, we are proud to be at an event that is dedicated to spreading awareness of its benefits," said HempMeds® President Todd Morrow. "We are excited to help consumers understand CBD products and their numerous health and wellness benefits."
The Cannabis World Congress and Business Expo is held three times a year in the largest media, financial and business markets: Los Angeles, New York and Boston. CBD will be a major topic at this year's conference in Los Angeles, as a new estimate from cannabis industry analysts The Brightfield Group estimates that the hemp-derived CBD market alone could hit $22 billion by 2022.
Recently announced HempMeds® President Todd Morrow will be at booth #106 with the company's spokesperson Liz Carmouche. Carmouche is an American MMA fighter who competed in the first-ever women's UFC fight and is an active CBD advocate, offering it at the MMA gyms she owns in San Diego. Attendees can also learn more about the company's unique line of CBD hemp oil supplements, including its award-winning brands like Dixie Botanicals®, Cannabis Beauty Defined® and Real Scientific Hemp Oil™.
HempMeds® was the first company to ever bring hemp-based CBD oil products to market in the U.S. in 2012 -- and the first to both make CBD products available in bulk for U.S. consumers and also provide high-quality CBD hemp oil to customers around the world. HempMeds® was also the first-ever company to receive historic federal government import approvals for its CBD products in the nations of Argentina, Brazil, Mexico and Paraguay.
"It is important that we continue to be included in the conversation surrounding CBD and clear up any misconceptions," said Medical Marijuana, Inc. Chief Executive Officer Dr. Stuart Titus. "HempMeds prides itself on providing people with the highest-quality hemp CBD products and the most comprehensive customer service."
The Cannabis World Congress and Business Expo exhibit hall will be open from 11:00 a.m. to 5 p.m. on Thursday, Sept. 27, and Friday, Sept. 28, and from 10 a.m. to 4 p.m. on Saturday, Sept. 29.
For more information on the company, stop by HempMeds® booth #106 or visit https://hempmedspx.com/.
HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC: MJNA) and the Company's exclusive master distributor and contracted marketing company, handling sales and distribution.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
SOURCE Medical Marijuana, Inc.